vs
Side-by-side financial comparison of FREQUENCY ELECTRONICS INC (FEIM) and Sight Sciences, Inc. (SGHT). Click either name above to swap in a different company.
Sight Sciences, Inc. is the larger business by last-quarter revenue ($20.4M vs $17.1M, roughly 1.2× FREQUENCY ELECTRONICS INC). FREQUENCY ELECTRONICS INC runs the higher net margin — 10.5% vs -20.4%, a 30.9% gap on every dollar of revenue. On growth, FREQUENCY ELECTRONICS INC posted the faster year-over-year revenue change (8.3% vs 6.9%). FREQUENCY ELECTRONICS INC produced more free cash flow last quarter ($-1.1M vs $-2.0M). Over the past eight quarters, FREQUENCY ELECTRONICS INC's revenue compounded faster (11.8% CAGR vs 2.9%).
Ultra Electronics Holdings is a British defence and security company. It was listed on the London Stock Exchange and was a constituent of the FTSE 250 Index until it was acquired by Cobham, which is itself owned by Advent International.
Sight Sciences, Inc. is a commercial-stage medical technology company focused on developing and commercializing innovative products for treating common eye conditions including glaucoma and dry eye disease. It offers minimally invasive surgical devices and non-surgical care solutions, primarily serving ophthalmology clinicians and patients across the United States.
FEIM vs SGHT — Head-to-Head
Income Statement — Q2 FY2026 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $17.1M | $20.4M |
| Net Profit | $1.8M | $-4.2M |
| Gross Margin | 38.2% | 87.3% |
| Operating Margin | 10.0% | -18.0% |
| Net Margin | 10.5% | -20.4% |
| Revenue YoY | 8.3% | 6.9% |
| Net Profit YoY | -32.1% | 64.9% |
| EPS (diluted) | $0.18 | $-0.07 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $17.1M | $20.4M | ||
| Q3 25 | $13.8M | $19.9M | ||
| Q2 25 | $20.0M | $19.6M | ||
| Q1 25 | $18.9M | $17.5M | ||
| Q4 24 | $15.8M | $19.1M | ||
| Q3 24 | $15.1M | $20.2M | ||
| Q2 24 | $15.6M | $21.4M | ||
| Q1 24 | $13.7M | $19.3M |
| Q4 25 | $1.8M | $-4.2M | ||
| Q3 25 | $634.0K | $-8.2M | ||
| Q2 25 | $3.2M | $-11.9M | ||
| Q1 25 | $15.4M | $-14.2M | ||
| Q4 24 | $2.7M | $-11.8M | ||
| Q3 24 | $2.4M | $-11.1M | ||
| Q2 24 | $2.6M | $-12.3M | ||
| Q1 24 | $130.0K | $-16.3M |
| Q4 25 | 38.2% | 87.3% | ||
| Q3 25 | 36.8% | 86.4% | ||
| Q2 25 | 37.5% | 84.8% | ||
| Q1 25 | 43.8% | 86.2% | ||
| Q4 24 | 48.2% | 86.8% | ||
| Q3 24 | 44.4% | 83.9% | ||
| Q2 24 | 40.3% | 85.8% | ||
| Q1 24 | 22.6% | 85.5% |
| Q4 25 | 10.0% | -18.0% | ||
| Q3 25 | 2.6% | -39.7% | ||
| Q2 25 | 16.4% | -59.6% | ||
| Q1 25 | 18.3% | -79.2% | ||
| Q4 24 | 16.5% | -62.5% | ||
| Q3 24 | 15.7% | -55.7% | ||
| Q2 24 | 16.0% | -59.2% | ||
| Q1 24 | -3.4% | -76.4% |
| Q4 25 | 10.5% | -20.4% | ||
| Q3 25 | 4.6% | -41.0% | ||
| Q2 25 | 16.0% | -61.0% | ||
| Q1 25 | 81.4% | -80.8% | ||
| Q4 24 | 16.8% | -62.1% | ||
| Q3 24 | 16.1% | -54.9% | ||
| Q2 24 | 16.9% | -57.7% | ||
| Q1 24 | 0.9% | -84.4% |
| Q4 25 | $0.18 | $-0.07 | ||
| Q3 25 | $0.07 | $-0.16 | ||
| Q2 25 | $0.33 | $-0.23 | ||
| Q1 25 | $1.60 | $-0.28 | ||
| Q4 24 | $0.28 | $-0.23 | ||
| Q3 24 | $0.25 | $-0.22 | ||
| Q2 24 | $0.28 | $-0.25 | ||
| Q1 24 | $0.01 | $-0.33 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $3.0M | $92.0M |
| Total DebtLower is stronger | — | $42.4M |
| Stockholders' EquityBook value | $58.5M | $63.9M |
| Total Assets | $92.3M | $115.3M |
| Debt / EquityLower = less leverage | — | 0.66× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $3.0M | $92.0M | ||
| Q3 25 | $4.5M | $92.4M | ||
| Q2 25 | $4.7M | $101.5M | ||
| Q1 25 | $5.5M | $108.8M | ||
| Q4 24 | $9.7M | $120.4M | ||
| Q3 24 | $16.2M | $118.6M | ||
| Q2 24 | $18.3M | $118.2M | ||
| Q1 24 | $11.7M | $127.3M |
| Q4 25 | — | $42.4M | ||
| Q3 25 | — | $42.4M | ||
| Q2 25 | — | $42.4M | ||
| Q1 25 | — | $42.4M | ||
| Q4 24 | — | $40.0M | ||
| Q3 24 | — | $37.1M | ||
| Q2 24 | — | $35.0M | ||
| Q1 24 | — | $35.0M |
| Q4 25 | $58.5M | $63.9M | ||
| Q3 25 | $56.3M | $64.3M | ||
| Q2 25 | $55.6M | $70.0M | ||
| Q1 25 | $51.8M | $77.6M | ||
| Q4 24 | $36.2M | $87.5M | ||
| Q3 24 | $33.2M | $95.0M | ||
| Q2 24 | $39.8M | $101.6M | ||
| Q1 24 | $36.7M | $109.2M |
| Q4 25 | $92.3M | $115.3M | ||
| Q3 25 | $93.2M | $116.3M | ||
| Q2 25 | $93.7M | $122.0M | ||
| Q1 25 | $86.4M | $129.7M | ||
| Q4 24 | $77.8M | $142.8M | ||
| Q3 24 | $84.3M | $143.6M | ||
| Q2 24 | $83.3M | $149.7M | ||
| Q1 24 | $77.7M | $155.6M |
| Q4 25 | — | 0.66× | ||
| Q3 25 | — | 0.66× | ||
| Q2 25 | — | 0.61× | ||
| Q1 25 | — | 0.55× | ||
| Q4 24 | — | 0.46× | ||
| Q3 24 | — | 0.39× | ||
| Q2 24 | — | 0.34× | ||
| Q1 24 | — | 0.32× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-523.0K | $-1.8M |
| Free Cash FlowOCF − Capex | $-1.1M | $-2.0M |
| FCF MarginFCF / Revenue | -6.6% | -9.7% |
| Capex IntensityCapex / Revenue | 3.6% | 0.8% |
| Cash ConversionOCF / Net Profit | -0.29× | — |
| TTM Free Cash FlowTrailing 4 quarters | $-5.5M | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-523.0K | $-1.8M | ||
| Q3 25 | $1.2M | $-8.7M | ||
| Q2 25 | $-155.0K | $-7.5M | ||
| Q1 25 | $-3.6M | $-11.6M | ||
| Q4 24 | $3.8M | $-3.5M | ||
| Q3 24 | $-1.5M | $362.0K | ||
| Q2 24 | $7.5M | $-9.5M | ||
| Q1 24 | $4.2M | $-9.8M |
| Q4 25 | $-1.1M | $-2.0M | ||
| Q3 25 | $385.0K | $-8.9M | ||
| Q2 25 | $-786.0K | $-7.8M | ||
| Q1 25 | $-4.0M | — | ||
| Q4 24 | $3.3M | $-3.6M | ||
| Q3 24 | $-1.8M | $311.0K | ||
| Q2 24 | $6.7M | $-9.5M | ||
| Q1 24 | $3.9M | $-9.9M |
| Q4 25 | -6.6% | -9.7% | ||
| Q3 25 | 2.8% | -44.7% | ||
| Q2 25 | -3.9% | -39.6% | ||
| Q1 25 | -20.9% | — | ||
| Q4 24 | 20.8% | -18.9% | ||
| Q3 24 | -11.8% | 1.5% | ||
| Q2 24 | 42.8% | -44.7% | ||
| Q1 24 | 28.4% | -51.4% |
| Q4 25 | 3.6% | 0.8% | ||
| Q3 25 | 5.6% | 0.9% | ||
| Q2 25 | 3.2% | 1.1% | ||
| Q1 25 | 1.7% | 0.0% | ||
| Q4 24 | 3.3% | 0.7% | ||
| Q3 24 | 2.2% | 0.3% | ||
| Q2 24 | 5.3% | 0.4% | ||
| Q1 24 | 2.3% | 0.6% |
| Q4 25 | -0.29× | — | ||
| Q3 25 | 1.83× | — | ||
| Q2 25 | -0.05× | — | ||
| Q1 25 | -0.24× | — | ||
| Q4 24 | 1.44× | — | ||
| Q3 24 | -0.60× | — | ||
| Q2 24 | 2.85× | — | ||
| Q1 24 | 32.36× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
FEIM
| POC Revenue | $14.8M | 86% |
| POT Revenue | $2.3M | 13% |
SGHT
| Surgical Glaucoma | $19.7M | 96% |
| Other | $724.0K | 4% |
